Market Strategist Says XRP Just Got A Huge Green Light. Here’s why
XRP and the broader cryptocurrency market could benefit from a cleaner regulatory environment in the United States, according to finance expert Levi.
Levi focused on comments from CFTC Chair Mike Selig, who said that “clear rules of the road start now.” Levi interpreted the statement as a sign that US regulators are moving toward a more defined structure for cryptocurrency markets rather than leaving companies and exchanges to operate under regulatory uncertainty.
The financial expert described the development as a major shift for the US crypto industry. He explained that clearer requirements could give companies greater certainty when developing products and operating within the American market.
Levi Connects Regulatory Clarity to XRP
Levi emphasized the potential effects of clearer crypto rules on market participation. He said that regulatory clarity could allow more companies to build within the United States while giving institutions greater confidence to enter the digital asset market.
He specifically connected those potential developments to XRP. Levi described the regulatory environment as the type of development XRP holders have been waiting for, suggesting that greater certainty around crypto regulation could create more favorable conditions for XRP and other digital assets.
However, Levi’s comments represent his interpretation of the regulatory development and its potential market impact. Clearer rules do not automatically guarantee higher prices for XRP or other cryptocurrencies. Market conditions, institutional demand, liquidity, and the eventual implementation of regulatory requirements will also influence how digital assets perform.
Levi Predicts Stronger Crypto Prices
Levi also offered a bullish outlook for the cryptocurrency market if the United States continues moving toward clearer rules. He said he expects crypto prices to move significantly higher if regulators maintain this direction.
In his video, Levi described the CFTC’s actions as the beginning of a new regulatory phase for the US crypto market. He argued that greater certainty could encourage additional investment and business activity, particularly from participants who previously remained cautious because of regulatory uncertainty.
Levi ended his message by urging his audience to prepare for what he believes could become a stronger period for crypto markets. He maintained that “green days” could be close if the regulatory environment continues to develop in the direction outlined by the CFTC.
For XRP holders, Levi’s comments place regulatory clarity at the center of the asset’s potential outlook.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SK hynix (SKHY.US) subsidiary Flash Division reportedly selects Goldman Sachs and Morgan Stanley to lead, aiming for a US IPO in 2027
According to sources familiar with the matter, Solidigm, the flash memory subsidiary of SK hynix (SKHY.US), has selected the lead banks for its planned US IPO next year, with Goldman Sachs and Morgan Stanley responsible for the offering.
KS Industry holds extraordinary shareholder meeting, elects directors
KS Industry held an extraordinary shareholder meeting on Oct. 8, 2026. Shareholders passed resolutions to appoint Kim In-gyeom as an internal director. Approval was also secured to appoint Chen Yang as an internal director. Resolutions to appoint Kim Woo-joon, Cha Haeng-jeon as independent directors were adopted. The votes authorized these board appointments; the filing did not confirm the appointments have been implemented. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KS Industry Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008900252), on October 08, 2026, and is solely responsible for the information contained therein.
Pfizer (PFE.US) Tukysa approved in the United States for first-line breast cancer treatment
Pfizer (PFE.US) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its tyrosine kinase inhibitor, Tukysa (tucatinib), as part of a combination regimen for first-line maintenance treatment of a certain type of breast cancer.
Veteran Danny Deep from General Dynamics appointed as the next CEO
